1. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47:127–141.
2. Lee EH, Park B, Kim NS, Seo HJ, Ko KL, Min JW, Shin MH, Lee K, Lee S, Choi N, Hur MH, Kim DI, Kim MJ, Kim SY, Sunwoo S, Dang JY, Kim SY, Kim Y, Lee WC, Jeong J. The Korean guideline for breast cancer screening. J Korean Med Assoc. 2015; 58:408–419.
3. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010; 102:605–613.
4. Bae JM. Overdiagnosis: epidemiologic concepts and estimation. Epidemiol Health. 2015; 37:e2015004.
5. Bae JM. Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean. Epidemiol Health. 2015; 37:e2015015.
Article
7. Canadian Task Force on Preventive Health Care. Tonelli M, Connor Gorber S, Joffres M, Dickinson J, Singh H, Lewin G, Birtwhistle R, Fitzpatrick-Lewis D, Hodgson N, Ciliska D, Gauld M, Liu YY. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ. 2011; 183:1991–2001.
Article
8. Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013; 6:CD001877.
Article
9. Loberg M, Lousdal ML, Bretthauer M, Kalager M. Benefits and harms of mammography screening. Breast Cancer Res. 2015; 17:63.
10. Bae JM. On the benefits and harms of mammography for breast cancer screening in Korean women. Korean J Fam Pract. 2014; 4:1–6.